AI ResearchThe Decoder·September 7, 2026

AI-designed drug appears to turn back the body's biological clock in early trial

A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42 patients and the drug hasn't been tested in healthy people yet. The article AI-designed drug appears…

This is a summary curated by AIFuture. Read the complete article at the original source:

Read the full story on The Decoder

More AI News

ProductMarkTechPost

Reducto Releases r-1: A Single Pass Document Parsing Model That Cuts Errors 20% at 1 Cent Per Page

We look at r-1, the document parsing model Reducto released on September 1, 2026. We walk through how it folds OCR, layout detection, tables, formatting and grounding into one full page pass, replacing the multi stage agentic pipeline it ships alongside. We break down the two numbers that matter for a migration decision: a reported 20% error reduction and a flat 1 cent per page rate against the…

Sep 8, 2026

IndustryTechCrunch

Opaque recurrence, and other AI terms that you should probably know

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most important words and phrases you might encounter.

Sep 7, 2026

RegulationMarkTechPost

OpenBMB Releases MiniCPM5-2B: A 2.52B Dense Model Averaging 53.9 Across 34 Benchmarks and Built to Run On Device

OpenBMB has released MiniCPM5-2B, a dense causal language model with 2,516,756,480 parameters and a native 131,072 token context. It averages 53.9 across the 34 benchmarks in its model card, ahead of Qwen3.5-4B at 51.1, with its clearest leads in tool use, coding agents and long-context retrieval. Post-training pairs 400B tokens of deep-thinking SFT with RL teachers and on-policy distillation…

Sep 7, 2026